Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% |
|
0.00% | 0.00% |
2020 | Abattis Bioceuticals Corp. Reports Earnings Results for the Full Year Ended September 30, 2019 | CI |
2019 | Abattis Bioceuticals Corp. Announces Board Changes | CI |
1st Jan change | Capi. | |
---|---|---|
0.00% | 476 | |
+22.22% | 24Cr | |
+35.47% | 18Cr | |
-13.40% | 17Cr | |
-42.86% | 12Cr | |
+29.96% | 12Cr | |
+270.00% | 11Cr | |
+92.01% | 11Cr | |
-52.02% | 10Cr | |
+7.69% | 9.36Cr |
- Stock Market
- Equities
- ATTBF Stock
- News Abattis Bioceuticals Corp.
- Abattis Bioceuticals Corp. announced that it has received CAD 6.71332 million in funding